Forward Citations = 104

Loading Chart...

8 inventors (with patents filed for the assignee):

Claudio Cavazza (2 out of 110 patents)

Mauro Marzi (2 out of 25 patents)

Maria Ornella Tinti (2 out of 81 patents)

4. Piero Foresta (2 out of 17 patents)

5. Paolo Carminati (1 out of 37 patents)

6. Arduino Arduini (1 out of 9 patents)

7. Paolo De Witt (1 out of 12 patents)

8. Alessandro Peschechera (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 6245800 - Method of preventing or treating statin-induced toxic effects using L-carnitine or an alkanoyl L-carnitine (2001-06-12),

2. 5962525 - 6,7-disubstituted-2-aminotetralines active as immunomodulators and (1999-10-05),

3. 5637614 - 6,7-disubstituted-2-aminotetralines and pharmaceutical compositions (1997-06-10),

4. 4401827 - Novel acyl-derivatives of carnitine and process for their preparation (1983-08-30),

5. 4100289 - Amidic derivatives of nicotinic acid as therapeutics (1978-07-11),

6. 3968872 - Device, provided with a puncher and a dripper, for the hermetic sealing (1976-07-13),

Company Overview

Sigma-tau is a pharmaceutical company dedicated to developing and providing innovative treatments for various medical conditions. With a focus on research and development, Sigma-tau strives to improve the lives of patients worldwide through the discovery of new therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#55 in Rome

#1,397 in Italy

Rome, Italy

Sigma-Tau

Forward Citations = 104

8 inventors:

Claudio Cavazza (2 out of 110 patents)

Mauro Marzi (2 out of 25 patents)

Maria Ornella Tinti (2 out of 81 patents)

4. Piero Foresta (2 out of 17 patents)

5. Paolo Carminati (1 out of 37 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sigma-Tau. Retrieved from https://idiyas.com/company/sigma-tau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]